Lilly obesity-pill trial results find a warmer reception on Wall Street
Pharmaceutical giant Eli Lilly said it will now move “with urgency” toward getting regulatory approval for orforglipron.
Read More: Lilly obesity-pill trial results find a warmer reception on Wall Street